Serum biomarkers such as N‐terminal pro‐b‐type natriuretic peptide (NT‐pro‐BNP) and high‐sensitivity cardiac troponin I (hs‐cTnI) have also been found to be predictors of cardiac outcomes after MI (Radosavljevic‐Radovanovic et al., 2016) (Jansen et al., 2019). Here, TNNI3 is linked to myocardial infarction.